These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4130126)

  • 21. The use of cell separation techniques and isantibody to host antigens in the treatent of severe combined immunodeficiency disease with HL-A incompatible maternal marrow.
    Gelfand EW; Phillips RA; Miller RG; McCulloch EA; Rosen FS
    Exp Hematol; 1974; 2(3):122-30. PubMed ID: 4156326
    [No Abstract]   [Full Text] [Related]  

  • 22. Reconstitution of Clq after bone marrow transplantation in patients with severe combined immunodeficiency.
    Ballow M; Day NK; Biggar WD; Park BH; Yount WJ; Good RA
    Clin Immunol Immunopathol; 1973 Nov; 2(1):28-35. PubMed ID: 4272769
    [No Abstract]   [Full Text] [Related]  

  • 23. Is HL-A typing of clinical significance in cadaver renal transplantation?
    Belzer FO; Perkins HA; Fortmann JL; Kountz SL; Salvatierra O; Cochrum KC; Payne R
    Lancet; 1974 Apr; 1(7861):774-7. PubMed ID: 4132709
    [No Abstract]   [Full Text] [Related]  

  • 24. Canine marrow transplantation: are serum blocking factors necessary to maintain the stable chimeric state?
    Tsoi MS; Storb R; Weiden PL; Graham TC; Schroeder ML; Thomas ED
    J Immunol; 1975 Feb; 114(2 Pt 1):531-9. PubMed ID: 1091699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of severe combined immunodeficiency by a small number of pretreated nonmatched marrow cells.
    Huang SW; Ammann AJ; Levy RL; Hong R; Bach FH
    Transplantation; 1973 Jan; 15(1):174-6. PubMed ID: 4145722
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tissue typing before bone marrow transplantation].
    Kosinski S
    Postepy Hig Med Dosw; 1979; 33(3):221-38. PubMed ID: 42045
    [No Abstract]   [Full Text] [Related]  

  • 27. Functional characterization of blocking antibody after human renal transplantation.
    Miller J; Lifton J; Rood F; Kyriakides G; Gajl-Peczalska KY; Yunis EJ; Hattler BG
    Surgery; 1974 Jul; 76(1):129-41. PubMed ID: 4135311
    [No Abstract]   [Full Text] [Related]  

  • 28. Transplantation of incompatible bone marrow in infants with severe combined immunodeficiency disease.
    Park BY; Biggar WD; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):380-4. PubMed ID: 238680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major and minor histocompatibility systems in man and their importance in bone marrow transplantation.
    van Rood JJ; van Leeuwen A
    Transplant Proc; 1976 Sep; 8(3):429-36. PubMed ID: 62433
    [No Abstract]   [Full Text] [Related]  

  • 30. Nature of reconstitution with histoincompatible maternal marrow in a case of severe combined immunodeficiency with graft-versus-host disease following maternofetal transfusion.
    Niethammer D; Goldmann SF; Flad HD; Bienzle U; Dieterle U; Haas RJ; Heymer B; Meigel W; Belohradsky BH; Kleihauer E
    Clin Immunol Immunopathol; 1981 Mar; 18(3):387-401. PubMed ID: 7018767
    [No Abstract]   [Full Text] [Related]  

  • 31. The HL-A system. I. Genetics and molecular biology.
    Ceppellini R; van Rood JJ
    Semin Hematol; 1974 Jul; 11(3):233-51. PubMed ID: 4151844
    [No Abstract]   [Full Text] [Related]  

  • 32. [Limitations of the nonimmune lymphocyte transfer test as a method of selecting donors for transplantation (a review of the literature)].
    Shereshkov SI
    Probl Gematol Pereliv Krovi; 1973 May; 18(5):47-52. PubMed ID: 4150019
    [No Abstract]   [Full Text] [Related]  

  • 33. Extraneous lymphocytic HL-A antigens in severe combined immunodeficiency disease.
    Terasaki PI; Miyajima T; Sengar DP; Stiehm ER
    Transplantation; 1972 Mar; 13(3):250-5. PubMed ID: 4112149
    [No Abstract]   [Full Text] [Related]  

  • 34. Compatible bone marrow transplantation and immunologic reconstitution of combined immunodeficiency disease.
    Biggar WD; Park BH; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):385-90. PubMed ID: 238681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplantation in severe combined immunodeficiency disease with hl-a identical bone marrow.
    Gelfand EW; Parkman R; Rosen FS
    Birth Defects Orig Artic Ser; 1975; 11(1):409-16. PubMed ID: 238684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic reconstitution in severe combined immunodeficiency following transplantation with parental bone marrow.
    Geha RS; Malakian A; LeFranc G; Chayban D; Serre JL
    Pediatrics; 1976 Sep; 58(3):451-5. PubMed ID: 785357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental basis of bone marrow transplantation.
    van Bekkum DW
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1562-7. PubMed ID: 4405055
    [No Abstract]   [Full Text] [Related]  

  • 38. Circumvention of early graft-versus-host disease in hemiallogeneic bone marrow transplantation in a case of severe combined immunodeficiency.
    Scand J Immunol; 1973; 2(5):551-61. PubMed ID: 4149578
    [No Abstract]   [Full Text] [Related]  

  • 39. [Demonstration of lymphocytotoxic antibodies directed against A and B antigens and against non HL-A histocompatibility antigens. Preliminary communication].
    Jeannet M; Schapira M; Magnin C
    Schweiz Med Wochenschr; 1974 Jan; 104(4):152. PubMed ID: 4590411
    [No Abstract]   [Full Text] [Related]  

  • 40. Histocompatibility in humans.
    Fotino M
    Ann Clin Lab Sci (1971); 1971; 1(2):125-30. PubMed ID: 4405210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.